ARCHIVES

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

NCI Failed to Publish Two Bypass Budgets As Funds Tightened and Sequestration Set In

October 10, 2014

TV Networks Donate A Prime-Time Hour To Raise Funds For Cancer Research; AACR To Administer Funds, Select Research “Dream Teams.”

May 30, 2008

41 CCOPs Reported For Recompetition

February 23, 1990

CCIRC Reviews Two Existing, One Prospective Cooperative Group

March 4, 1977

Obey Attacks NCI, Eppley, Shubick, Asks for Full Report From GAO

June 10, 1977

Study Tests PARP Inhibitor ABT-888 For Several Cancers

September 25, 2009